Act Now! Don’t Miss Out on Your Chance to Recover Losses with The Portnoy Law Firm – Deadline: November 7, 2022

Act Now! Don’t Miss Out on Your Chance to Recover Losses with The Portnoy Law Firm – Deadline: November 7, 2022 LOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ: SMFR, SMFRW) investors that a class action has been filed on behalf of…

Read More

Revolutionizing the Flooring Industry: Market Predicts a 5.2% CAGR and USD 18,071.8 Million Growth for Floor Polishing Machines by 2030 – Market Research Future (MRFR) Report

The Growing Construction Industry and Rapid Technological Advances New York, US, Nov. 07, 2022 (GLOBE NEWSWIRE) — According to a comprehensive research report by Market Research Future (MRFR), “Floor Polishing Machine Market Research Report: Information by Operation, Floor Type, Application, Sales Channel and Region —Forecast till 2030”, states that the global floor polishing machine market…

Read More

Bronstein Gewirtz Grossman LLC: A Leading Firm Notifies CMP Investors of Class Action and Encourages Active Participation

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Lawsuit Against Compass Minerals International, Inc. NY, Nov. 07, 2022 (GLOBE NEWSWIRE) — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a top firm in the legal world, has recently notified investors about a class action lawsuit that has been filed against Compass Minerals International, Inc….

Read More

Revolutionizing Carbon Capture: L.B. Foster and ACIPCO Team Up to Supply Coated Pipe for Summit Carbon Solutions’ 2000-Mile Pipeline

Revolutionizing Carbon Capture: L.B. Foster and ACIPCO Team Up to Supply Coated Pipe for Summit Carbon Solutions’ 2000-Mile Pipeline Description: PITTSBURGH, Nov. 07, 2022 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR), a global solutions provider of products and services for the rail and infrastructure markets (“L.B. Foster” or the “Company”), today announced that the…

Read More

Unveiling the Power of ALAUNOS Therapeutics: A Look into their Revolutionary HUNTR TCR Discovery Platform at the Society for Immunotherapy of Cancer’s 2022 Annual Meeting

Alaunos Therapeutics to Present Data High… Data supports high-throughput screening process to identify neoantigen-reactive TCRs Exclusive ownership of discovered KRAS mutation-reactive TCRs hunTR enables expansion of the Company’s hotspot mutation targeted TCR library HOUSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company…

Read More